Sylentis attended Association for Research in Vision and Ophthalmology Congress (ARVO) which was held on 5th to 10th May 2008 in Florida.

The company announced EPOC results concerning to its research in Glaucoma treatment, and presented a poster during the event which includes concrete results in Ocular Hypertension parameters from different interference RNA (RNAi) experiments.

Research has been carried out in collaboration with several Spanish universities and research centres.